ACHV Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expenses
18.5M
+76.7%
10.5M
-30.9%
15.1M
+3.0%
14.7M
+16.1%
12.7M
R&D
3.8M
+15.7%
3.3M
-15.0%
3.9M
-27.2%
5.3M
-20.7%
6.7M
SG&A
14.6M
+103.4%
7.2M
-34.0%
10.9M
+15.8%
9.4M
+60.0%
5.9M
Operating Income
-18492000
-76.7%
-10463000
+30.9%
-15139000
-3.0%
-14692000
-16.1%
-12660000
EBITDA
-18434000
-77.1%
-10406000
+29.1%
-14674000
-0.2%
-14638000
-16.1%
-12605000
Net Income
-74769000
-635.3%
-10168000
+30.7%
-14662000
-1.5%
-14441000
-13.5%
-12718000
EPS (Basic)
$-0.80
-321.1%
$-0.19
+29.6%
$-0.27
+3.6%
$-0.28
+24.3%
$-0.37
EPS (Diluted)
$-0.80
-321.1%
$-0.19
+29.6%
$-0.27
+3.6%
$-0.28
+24.3%
$-0.37
Shares (Diluted)
93.5M
+75.2%
53.4M
-1.1%
54.0M
+5.8%
51.0M
+47.1%
34.7M
Achieve Life Sciences (ACHV) โ€” Financials